oxycodone

(redirected from Oxecta)
Also found in: Dictionary.

oxycodone

 [ok″se-ko´dōn]
an opioid analgesic derived from morphine; used in the form of the hydrochloride and terephthalate salts, administered orally or rectally.

ox·y·co·done

(ok'sē-kō'dōn),
A narcotic analgesic often prepared with aspirin or acetaminophen.

oxycodone

/oxy·co·done/ (-ko´dōn) an opioid analgesic derived from morphine; used in the form of the hydrochloride and terephthalate salts.

oxycodone

(ŏk′sĭ-kō′dōn′)
n.
A semisynthetic opioid drug, C18H21NO4, used in its hydrochloride form as a pain reliever, often in combination with nonopioid analgesics such as acetaminophen.

oxycodone

Hillbilly heroin, poor man's heroin, redneck heroin Pharmacology An oral opioid analgesic, which may be coadministered with other analgesics Pharmacologic effects Morphine-like actions; blocks CNS responses to pain; CNS depressant; analgesic. See Opioids, OxyContin.

ox·y·co·done

(ok'sē-kō'dōn)
A narcotic analgesic often prepared with aspirin or acetaminophen.

oxycodone (ok´sēkō´dōn),

n brand name: Roxicodone; OxyIR; OxyContin;
drug class: synthetic opioid analgesic (Controlled Substance Schedule II);
action: attaches to opiate receptors in the central nervous system;
uses: moderate to severe pain, normally used in combination with aspirin or acetaminophen, the opioid found in Percodan, Percocet, and Tylox. It is an easily abused substance. See also Percocet and Percodan.

oxycodone

a semisynthetic narcotic analgesic derived from morphine.
References in periodicals archive ?
Pfizer received the US Food and Drug Administration (FDA) approval in Jun 2011 for its New Drug Application (NDA) for Oxecta.
Pfizer will transfer Acura all studies, data, regulatory filings (including the NDA) and other information relating to Oxecta.
We are pleased to bring OXECTA to patients and physicians with our partner Acura.
We are excited to be partnered with Pfizer to bring OXECTA to patients who need opioids to manage their pain," said Robert Jones, interim president and chief executive officer of Acura Pharmaceuticals, Inc.
Respiratory depression is the primary risk of OXECTA.
OXECTA can be abused in a manner similar to other opioids and narcotics.
There is no evidence that OXECTA has a reduced abuse liability compared to immediate-release oxycodone.
Take each OXECTA tablet with enough water to ensure complete swallowing immediately after placing in the mouth, and OXECTA must be swallowed whole.
Patients who have not been receiving opioid analgesics should start on OXECTA in a dosing range of 5 to 15 mg every 4 to 6 hours as needed for pain.
Patients taking OXECTA in combination with other medicines like sedatives, anesthetics or narcotics may have serious problems such as respiratory depression, low blood pressure, profound sedation, or coma.
Use OXECTA with caution in patients with head injuries or other conditions that increase pressure in the brain, shock with low blood volume, severe undiagnosed abdominal conditions, history of seizures, severe kidney or liver disease, gall bladder disease, Addison's disease, hypothyroidism, enlarged prostate or other illnesses that make urination difficult and elderly or debilitated patients.
Patients taking OXECTA should use caution when driving a car, operating heavy machinery or doing similar, potentially dangerous tasks as OXECTA may impair abilities needed to drive or perform potentially dangerous activities.